Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism 17β-HSD1 inhibitors(Estradiol 17-beta-dehydrogenase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | Czechia | 30 Oct 2024 |